Echo Street Capital Management’s Novavax NVAX Stock Holding History

Echo Street Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,035	Closed	-$255K	–	607
2022 Q3	$255K	Buy	+14,035	New	+$608K	﹤0.01%	442
2022 Q2	–	Sell	-12,732	Closed	-$938K	–	660
2022 Q1	$938K	Buy	12,732 +7,101	+126%	+$633K	0.01%	249
2021 Q4	$806K	Buy	5,631 +3,006	+115%	+$516K	0.01%	298
2021 Q3	$544K	Sell	2,625 -3,047	-54%	-$672K	﹤0.01%	394
2021 Q2	$1.2M	Buy	5,672 +3,590	+172%	+$658K	0.01%	182
2021 Q1	$377K	Buy	+2,082	New	+$415K	﹤0.01%	374

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIG

Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Echo Street Capital Management's NVAX Position: Q4 2022 in Review

Echo Street Capital Management sold out of Novavax (NVAX) in Q4 2022, closing a stake of 14,035 shares — an estimated $255K sold.

Echo Street Capital Management first reported a position in NVAX in Q1 2021 and held it in 6 quarters. The position peaked at $1.2M in Q2 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

Echo Street Capital Management reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
Echo Street Capital Management sold 14,035 Novavax shares in Q4 2022, an estimated $255K.
Echo Street Capital Management first reported a position in Novavax in Q1 2021 and held it in 6 quarters.
Echo Street Capital Management's Novavax position peaked at $1.2M in Q2 2021.
252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.